Stayble Therapeutics

Göteborg, Sweden

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.

$463K raised

May 2025

Post-IPO Equity

Biotechnology Health Care Medical Device Therapeutics

Top Investors

Almi Invest Chalmers Ventures AB EISMEA

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Stayble Therapeutics

How much funding has Stayble Therapeutics raised?

Stayble Therapeutics has raised $463K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2025.

Who are Stayble Therapeutics's investors?

Stayble Therapeutics's investors include Almi Invest, Chalmers Ventures AB, EISMEA.

Where is Stayble Therapeutics headquartered?

Stayble Therapeutics is headquartered in Göteborg, Sweden.

What does Stayble Therapeutics do?

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.

What stage is Stayble Therapeutics at?

Stayble Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 12, 2025.

MLA

"Stayble Therapeutics — Funding & Investors." VCBacked, May 12, 2025, https://www.vcbacked.co/company/stayble-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2025). Stayble Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/stayble-therapeutics

Wikipedia (cite web)

{{cite web |title=Stayble Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/stayble-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 12, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K